Chairman and CEO of BioMed Realty Trust Inc. (BMR, Financial) Alan D Gold sells 28,000 shares of BMR on 11/02/2009 at an average price of $13.97 a share.
Biomed Realty Trust is focused on acquiring owning leasing managing and selectively developing laboratory and office space for lease to life science tenants including biotechnology and pharmaceutical companies scientific research institutes government agencies and other entities involved in the life science industry. The Company targets properties located in certain markets with established reputations as centers for scientific research including San Diego San Francisco Seattle Maryland Pennsylvania New York/New Jersey and Boston. Biomed Realty Trust Inc. has a market cap of $1.39 billion; its shares were traded at around $14.18 with a P/E ratio of 7.7 and P/S ratio of 4.6. The dividend yield of Biomed Realty Trust Inc. stocks is 3.1%.
Biomed Realty Trust is focused on acquiring owning leasing managing and selectively developing laboratory and office space for lease to life science tenants including biotechnology and pharmaceutical companies scientific research institutes government agencies and other entities involved in the life science industry. The Company targets properties located in certain markets with established reputations as centers for scientific research including San Diego San Francisco Seattle Maryland Pennsylvania New York/New Jersey and Boston. Biomed Realty Trust Inc. has a market cap of $1.39 billion; its shares were traded at around $14.18 with a P/E ratio of 7.7 and P/S ratio of 4.6. The dividend yield of Biomed Realty Trust Inc. stocks is 3.1%.
Insiders' Positions with BMR
- Sell:: Chairman and CEO Alan D Gold sold 50,000 shares of BMR stock on 10/28/2009 at the average price of 13.31, the price of the stock has increased by 6.54% since
- Sell:: Chairman and CEO Alan D Gold sold 50,000 shares of BMR stock on 08/05/2009 at the average price of 12.36, the price of the stock has increased by 14.72% since
- Sell:: Chairman and CEO Alan D Gold sold 50,000 shares of BMR stock on 07/30/2009 at the average price of 11.28, the price of the stock has increased by 25.71% since
Insiders' Positions with BMR
- Sell:: EVP, Acquisitions & Leasing Matthew G Mcdevitt sold 17,000 shares of BMR stock on 08/10/2009 at the average price of 14.04, the price of the stock has increased by 1% since
- Sell:: EVP, Acquisitions & Leasing Matthew G Mcdevitt sold 44,541 shares of BMR stock on 06/15/2009 at the average price of 10.07, the price of the stock has increased by 40.81% since
